Back
Invesco S&P 500 Eql Wght Financials ETF Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
41
RSPF
Invesco S&P 500 Eql Wght Financials ETF
Last Price:
$74.36
Seasonality Move:
1.21%
Sell
30
DRUG
Bright Minds Biosciences
Last Price:
$35.58
Seasonality Move:
-44.9%
Sell
41
Invesco S&P 500 Eql Wght Financials ETF (RSPF)
is a Sell
Is Invesco S&P 500 Eql Wght Financials ETF a Buy, Sell or Hold?
-
The current Invesco S&P 500 Eql Wght Financials ETF [RSPF] share price is $73.80. The Score for RSPF is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
RSPF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $35.99. The Score for DRUG is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RSPF Stock Price Chart
What is Invesco S&P 500 Eql Wght Financials ETF's stock price today?
-
The Invesco S&P 500 Eql Wght Financials ETF share price today is $73.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSPF is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $35.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
RSPF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 42.79 | Sell |
Chaikin Money Flow: | -5087 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (74.46 - 76.1) | Sell |
Bollinger Bands (100): | (71.14 - 76.04) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 43.58 | Sell |
Chaikin Money Flow: | -57932 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.31 - 42.33) | Sell |
Bollinger Bands (100): | (21.62 - 49.12) | Buy |
RSPF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 74.81 | Sell |
20-day SMA: | 75.43 | Sell |
50-day SMA: | 74.15 | Sell |
200-day SMA: | 68.88 | Buy |
8-day EMA: | 74.82 | Sell |
20-day EMA: | 74.92 | Sell |
50-day EMA: | 74.42 | Sell |
200-day EMA: | 69.63 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.66 | Sell |
20-day SMA: | 37.92 | Sell |
50-day SMA: | 38 | Sell |
200-day SMA: | 18.24 | Buy |
8-day EMA: | 38.81 | Sell |
20-day EMA: | 38.81 | Sell |
50-day EMA: | 37.51 | Sell |
200-day EMA: | 23.7 | Buy |
Invesco S&P 500 Eql Wght Financials ETF Earnings Growth & RSPF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
Invesco S&P 500 Eql Wght Financials ETF Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |